Vol 58, No 6 (2007)
Original paper
Published online: 2007-11-21
The blood concentration of intercellular adhesion molecule-1 (sICAM-1) and vascular cell adhesion molecule-1 (sVCAM-1) in patients with active thyroid-associated orbitopathy before and after methylprednisolone treatment
Endokrynol Pol 2007;58(6):487-491.
Abstract
Background: The soluble forms of vascular cell adhesion molecule-1 (sVCAM-1) and intercellular adhesion molecule-1
(sICAM-1) have been found to be increased in the blood of patients with Graves´ disease. The aim of this study is evaluation
of the serum concentrations of soluble forms of adhesion molecules ICAM-1 and VCAM-1 in patients with thyroid-associated
orbitopathy (TAO) before and after methylprednisolone treatment.
Material and methods: The study was performed in 40 Graves´disease, hyperthyroid and euthyroid patients with a clinically active form of TAO. Serum concentrations of sVCAM-1 and sICAM-1 in TAO patients were determined by enzymelinked immunoabsorbent assay (ELISA) before and after intensive pulse methylprednisolone treatment.
Results: We did not find any significant changes in the studied parameters between TAO patients with hyperthyroidism and those with euthyroidism. The serum concentrations of sICAM-1 and sVCAM-1 were significantly increased in patients with TAO before methylprednisolone therapy when compared with the control group. After treatment serum concentrations of sICAM-1 and sVCAM-1 decreased significantly but were still significantly higher than for the control group.
Conclusion: From the results obtained we can conclude that Graves´ orbitopathy itself but not thyroid function is probably responsible for the elevated level of the adhesion molecules studied.
Material and methods: The study was performed in 40 Graves´disease, hyperthyroid and euthyroid patients with a clinically active form of TAO. Serum concentrations of sVCAM-1 and sICAM-1 in TAO patients were determined by enzymelinked immunoabsorbent assay (ELISA) before and after intensive pulse methylprednisolone treatment.
Results: We did not find any significant changes in the studied parameters between TAO patients with hyperthyroidism and those with euthyroidism. The serum concentrations of sICAM-1 and sVCAM-1 were significantly increased in patients with TAO before methylprednisolone therapy when compared with the control group. After treatment serum concentrations of sICAM-1 and sVCAM-1 decreased significantly but were still significantly higher than for the control group.
Conclusion: From the results obtained we can conclude that Graves´ orbitopathy itself but not thyroid function is probably responsible for the elevated level of the adhesion molecules studied.
Keywords: adhesion moleculesthyroid-associated orbitopathy
![](https://journals.viamedica.pl/plugins/generic/popups/images/icons/close.png)